|1.||Lyngstadaas, S P: 3 articles (08/2009 - 06/2000)|
|2.||Sorsa, Timo: 2 articles (03/2010 - 08/2008)|
|3.||Laaksonen, Matti: 2 articles (03/2010 - 08/2008)|
|4.||Salo, Tuula: 2 articles (03/2010 - 08/2008)|
|5.||Brookes, S J: 2 articles (08/2009 - 01/2002)|
|6.||Selimovic, Denis: 2 articles (01/2008 - 10/2007)|
|7.||Miliauskaite, Asta: 2 articles (01/2008 - 10/2007)|
|8.||Filippi, Andreas: 2 articles (12/2006 - 06/2002)|
|9.||Pohl, Yango: 2 articles (12/2006 - 06/2002)|
|10.||von Arx, Thomas: 2 articles (12/2006 - 06/2002)|
01/01/2008 - "Papilla preservation technique combined with Emdogain in the treatment of intrabony defects: a novel treatment regimen for chronic periodontitis."
10/01/2001 - "Comparison of ready-to-use EMDOGAIN-gel and EMDOGAIN in patients with chronic adult periodontitis."
04/01/2003 - "This case report demonstrates a combined approach in topical application of EMD gel (Emdogain) and autogenous bone grafts for treatment of intrabony defects and furcation involvement defects in a patient with chronic periodontitis. "
07/01/2014 - "To evaluate and compare the efficacy of platelet-rich fibrin (PRF) with enamel matrix derivative (EMD; Emdogain) in the treatment of periodontal intrabony defects in patients with chronic periodontitis, six months after surgery. "
04/01/2012 - "This clinical study compared the results obtained by treating gingival recession using enamel matrix derivative (Emdogain gel(®)) along with coronally positioned flap and coronally positioned flap alone. "
05/01/2007 - "Enamel matrix derivative Emdogain as an adjuvant for a laterally-positioned flap in the treatment of gingival recession: an electron microscopic appraisal."
05/01/2007 - "Treatment of gingival recession using enamel matrix proteins: a case report with 4-year follow-up."
12/01/2003 - "This article describes the clinical procedure and outcome of surgical treatment of gingival recessions with the adjunctive use of Emdogain gel, an enamel matrix derivative bioactive material for periodontal reconstructive surgery. "
12/01/2003 - "Surgical treatment of gingival recessions using emdogain gel: clinical procedure and case reports."
|3.||Aggressive Periodontitis (Periodontosis)
10/01/2007 - "This case report presents a new treatment for localized aggressive periodontitis using surgery (papilla preservation technique [PPT]) combined with enamel matrix proteins and bioactive glass. "
10/01/2007 - "In the present case of aggressive periodontitis, application of enamel matrix proteins with or without the addition of bioactive glass resulted in the successful treatment of intrabony defects."
10/01/2007 - "Eight intrabony defects in a 19-year-old woman with localized aggressive periodontitis were treated by PPT and the application of enamel matrix proteins or enamel matrix proteins in combination with bioactive glass. "
04/01/2004 - "Clinical and radiographic evaluation of Emdogain as a regenerative material in the treatment of interproximal vertical defects in chronic and aggressive periodontitis patients."
01/01/2003 - "Use of Emdogain enamel matrix proteins in the surgical treatment of aggressive periodontitis."
11/01/2001 - "A common clinical observation following surgical periodontal therapy with an enamel matrix derivative (Emdogain) is the improved healing of the soft tissues and the limited inflammation of the operated areas. "
01/01/2014 - "Progressive inflammation and total pulp degeneration were only evident with Emdogain-treated group. "
02/01/2011 - "The porcine enamel matrix derivative, EMD(®), which is the active component of Emdogain(®), is used widely in periodontics because of its ability to promote the regeneration of soft and hard tissues and to reduce inflammation. "
|5.||Wounds and Injuries (Trauma)
10/01/2004 - "The aim of the present study was to examine, by clinical means and as patient perception of post-operative events, the effect of Emdogain (enamel matrix derivative (EMD)) on the healing of soft-tissue wounds following periodontal surgery in comparison to flap surgeries without application of EMD. "
04/01/2003 - "Staining for alpha-smooth muscle actin was abundant in the repopulating wound but was also unaffected by Emdogain. "
01/01/2002 - "The results indicated that Emdogain topically applied in instrumented pockets enhance the early healing of periodontal soft tissue wounds."
02/01/2010 - "The following in vitro translational study investigated whether enamel matrix derivative (EMD), an approved biomimetic treatment for periodontal disease (Emdogain) and hard-to-heal wounds (Xelma), enhanced synovial cell colonization and protein synthesis around a scaffold used clinically for in situ tissue engineering of the torn anterior cruciate ligament (ACL). "
01/01/2002 - "The aim of the present study was to evaluate by clinical means the effect of enamel matrix proteins on the healing of a soft tissue wound produced by periodontal pocket instrumentation. "
|3.||Intercellular Signaling Peptides and Proteins (Growth Factors)
|6.||enamel matrix proteins
|8.||Proteins (Proteins, Gene)
|10.||Edetic Acid (EDTA)
|5.||Guided Tissue Regeneration